ID

18327

Descrição

Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00075270

Link

https://clinicaltrials.gov/show/NCT00075270

Palavras-chave

Versões (2)
  1. 31/10/2016 31/10/2016 -
  2. 31/10/2016 31/10/2016 -
Transferido a

31 de outubro de 2016

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Neoplasms, Breast NCT00075270

Inglês

Eligibility Neoplasms, Breast NCT00075270

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
signed informed consent
Descrição

Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0021430
able to swallow an oral medication
Descrição

Able to swallow oral medication

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2712086
UMLS CUI [1,2]
C0175795
cardiac ejection fraction within the institutional range of normal as measured by echocardiogram
Descrição

Cardiac ejection fraction | Echocardiography

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232174
UMLS CUI [2]
C0013516
adequate kidney and liver function
Descrição

Renal function | Liver function

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0232804
UMLS CUI [2]
C0232741
adequate bone marrow function
Descrição

Bone Marrow function

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
tumor tissue available for testing
Descrição

Tumor tissue Available Testing

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C0039593
prior adjuvant or neoadjuvant therapy is permitted with an anthracycline or anthracenedione-containing regimen however, subjects must have had cumulative doses of less than 360 mg/m2 of doxorubicin, 720 mg/m2 of epirubicin, or 72 mg/m2 of mitoxantrone
Descrição

Adjuvant therapy | Neoadjuvant Therapy | Anthracycline Antibiotics | Anthraquinones | Doxorubicin Cumulative Dose | Epirubicin Cumulative Dose | Mitoxantrone Cumulative Dose

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0677850
UMLS CUI [2]
C0600558
UMLS CUI [3]
C0003234
UMLS CUI [4]
C0003174
UMLS CUI [5,1]
C0013089
UMLS CUI [5,2]
C2986497
UMLS CUI [6,1]
C0014582
UMLS CUI [6,2]
C2986497
UMLS CUI [7,1]
C0026259
UMLS CUI [7,2]
C2986497
no her2/neu overexpression in tumor tissue tested or status unknown if tissue has never been tested
Descrição

HER2/NEU Overexpression Tumor tissue | HER2/Neu Status Unknown

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C3810543
UMLS CUI [1,2]
C1514559
UMLS CUI [1,3]
C0475358
UMLS CUI [2]
C2348910
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment regimens for advanced or metastatic breast cancer.
Descrição

Prior Therapy Advanced breast cancer | Prior Therapy Breast Carcinoma Metastatic

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C3495917
UMLS CUI [2,1]
C1514463
UMLS CUI [2,2]
C0678222
UMLS CUI [2,3]
C0036525
pregnant or lactating
Descrição

Pregnancy | Breast Feeding

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
conditions that would effect the absorption of an oral drug
Descrição

Condition Affecting drug absorption

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0678745
active infection
Descrição

Communicable Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0009450
brain metastases
Descrição

Metastatic malignant neoplasm to brain

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0220650
treatment with egfr (endothelial growth factor receptor) inhibitor.
Descrição

Endothelial Growth Factor Receptor Inhibitors

Tipo de dados

boolean

Alias
UMLS CUI [1]
C2267120
known hypersensitivity to taxol or excipients of taxol
Descrição

HypersensitivityTaxol | Hypersensitivity Taxol Excipient

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0678133
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0678133
UMLS CUI [2,3]
C0015237
peripheral neuropathy of grade 2 or greater is not permitted
Descrição

Peripheral Neuropathy | CTCAE Grades

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
severe cardiovascular disease or cardiac disease requiring a device.
Descrição

Cardiovascular Disease Severe | Cardiovascular Disease Requirement Medical Device

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C1514873
UMLS CUI [2,3]
C0025080
serious medical or psychiatric disorder that would interfere with the patient's safety or informed consent.
Descrição

Disease Serious Interferes with patient safety | Disease Serious Interferes with Informed Consent | Mental disorder Interferes with patient safety | Mental disorder Interferes with Informed Consent

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C1113679
UMLS CUI [2,1]
C0012634
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C0521102
UMLS CUI [2,4]
C0021430
UMLS CUI [3,1]
C0004936
UMLS CUI [3,2]
C0521102
UMLS CUI [3,3]
C1113679
UMLS CUI [4,1]
C0004936
UMLS CUI [4,2]
C0521102
UMLS CUI [4,3]
C0021430
Voltar ao início da página

Similar models

Eligibility Neoplasms, Breast NCT00075270

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Able to swallow oral medication
Item
able to swallow an oral medication
boolean
C2712086 (UMLS CUI [1,1])
C0175795 (UMLS CUI [1,2])
Cardiac ejection fraction | Echocardiography
Item
cardiac ejection fraction within the institutional range of normal as measured by echocardiogram
boolean
C0232174 (UMLS CUI [1])
C0013516 (UMLS CUI [2])
Renal function | Liver function
Item
adequate kidney and liver function
boolean
C0232804 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
Bone Marrow function
Item
adequate bone marrow function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
Tumor tissue Available Testing
Item
tumor tissue available for testing
boolean
C0475358 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C0039593 (UMLS CUI [1,3])
Adjuvant therapy | Neoadjuvant Therapy | Anthracycline Antibiotics | Anthraquinones | Doxorubicin Cumulative Dose | Epirubicin Cumulative Dose | Mitoxantrone Cumulative Dose
Item
prior adjuvant or neoadjuvant therapy is permitted with an anthracycline or anthracenedione-containing regimen however, subjects must have had cumulative doses of less than 360 mg/m2 of doxorubicin, 720 mg/m2 of epirubicin, or 72 mg/m2 of mitoxantrone
boolean
C0677850 (UMLS CUI [1])
C0600558 (UMLS CUI [2])
C0003234 (UMLS CUI [3])
C0003174 (UMLS CUI [4])
C0013089 (UMLS CUI [5,1])
C2986497 (UMLS CUI [5,2])
C0014582 (UMLS CUI [6,1])
C2986497 (UMLS CUI [6,2])
C0026259 (UMLS CUI [7,1])
C2986497 (UMLS CUI [7,2])
HER2/NEU Overexpression Tumor tissue | HER2/Neu Status Unknown
Item
no her2/neu overexpression in tumor tissue tested or status unknown if tissue has never been tested
boolean
C3810543 (UMLS CUI [1,1])
C1514559 (UMLS CUI [1,2])
C0475358 (UMLS CUI [1,3])
C2348910 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Prior Therapy Advanced breast cancer | Prior Therapy Breast Carcinoma Metastatic
Item
prior treatment regimens for advanced or metastatic breast cancer.
boolean
C1514463 (UMLS CUI [1,1])
C3495917 (UMLS CUI [1,2])
C1514463 (UMLS CUI [2,1])
C0678222 (UMLS CUI [2,2])
C0036525 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Condition Affecting drug absorption
Item
conditions that would effect the absorption of an oral drug
boolean
C0348080 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0678745 (UMLS CUI [1,3])
Communicable Disease
Item
active infection
boolean
C0009450 (UMLS CUI [1])
Metastatic malignant neoplasm to brain
Item
brain metastases
boolean
C0220650 (UMLS CUI [1])
Endothelial Growth Factor Receptor Inhibitors
Item
treatment with egfr (endothelial growth factor receptor) inhibitor.
boolean
C2267120 (UMLS CUI [1])
HypersensitivityTaxol | Hypersensitivity Taxol Excipient
Item
known hypersensitivity to taxol or excipients of taxol
boolean
C0020517 (UMLS CUI [1,1])
C0678133 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0678133 (UMLS CUI [2,2])
C0015237 (UMLS CUI [2,3])
Peripheral Neuropathy | CTCAE Grades
Item
peripheral neuropathy of grade 2 or greater is not permitted
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Cardiovascular Disease Severe | Cardiovascular Disease Requirement Medical Device
Item
severe cardiovascular disease or cardiac disease requiring a device.
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0025080 (UMLS CUI [2,3])
Disease Serious Interferes with patient safety | Disease Serious Interferes with Informed Consent | Mental disorder Interferes with patient safety | Mental disorder Interferes with Informed Consent
Item
serious medical or psychiatric disorder that would interfere with the patient's safety or informed consent.
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C1113679 (UMLS CUI [1,4])
C0012634 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C0521102 (UMLS CUI [2,3])
C0021430 (UMLS CUI [2,4])
C0004936 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C1113679 (UMLS CUI [3,3])
C0004936 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0021430 (UMLS CUI [4,3])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial